论文部分内容阅读
近年来,国内已有大量资料报道了米非司酮配伍米索前列醇终止49天或56天内妊娠的临床研究, 其流产率都在90％～95％以上。目前,对米非司酮和米索前列醇终止妊娠56天以上的研究也在进行之中。我们总结了本所1995年1月至1995年6月期间应用米非司酮(息隐)配伍米索前列醇终止8～14周妊娠的药物流产效果,报告如下。材料与方法一、药物米非司酮(息隐),25mg/片,上海华联制药公司生产。米索前列醇,200μg/片,澳大利亚Searle公司生产。
In recent years, a large number of domestic reports of mifepristone with misoprostol termination of 49 days or 56 days of pregnancy clinical research, the abortion rate of 90% to 95%. Currently, more than 56 days of pregnancy termination of mifepristone and misoprostol are underway. We summarize the abortion effect of the application of mifepristone (misoprostol) combined with misoprostol in terminating pregnancies of 8 to 14 weeks between January 1995 and June 1995, and the report is as follows. Materials and methods First, the drug mifepristone (interest hidden), 25mg / tablet, Shanghai Hualian Pharmaceutical Company. Misoprostol, 200 μg / tablet, manufactured by Searle, Australia.